Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aol
artificial intelligence
biotech
blogs
boston
boston blog main
boston top stories
brexanalone
ceo
clinical data
depression
digital media
funding
health
jeff jonas
life sciences
machine learning
major depressive disorder
mental illness
national blog main
national top stories
neuroscience
one medical
phase 3 trial
postpartum depression
psychiatric disorders
sage therapeutics
tc
techcrunch
the carlyle group
uber
united states
world wide web
What
infusion
2
×
medical
stock
2
×
announcement
approval
brexanalone
carlyle
cash
close
closed
confirmed
deal
depression
double
drug
earlier
fda
financin
follows
funding
group
help
hits
hour
mark
million
new
offerings
offices
phase
possible
postpartum
ppd
raises
report
sage
seeking
soon
supervised
surges
Language
Current search:
stock
×
infusion
×
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@techcrunch.com
5 years ago
One Medical raises $350 million from Carlyle Group to help double up offices and offerings
